By Ben HirschlerLONDON (Reuters UK) - GlaxoSmithKline's GSK top-selling respiratory drug Advair is set to lose business to Spiriva, marketed by Pfizer PFE and Boehringer Ingelheim, according to analysts at Morgan Stanley.The brokerage said on Friday it was cutting earnings per share forecasts for Glaxo, the world's second-biggest drugmaker, by...
RESEARCH TRIANGLE PARK, N.C. -- Oriel Therapeutics announced that effective immediately Richard Rick Fuller, M.D., a former senior executive at GlaxoSmithKline, has joined Oriel as Chief Executive Officer. Dr. Fuller brings 30 years of experience in the healthcare field. During his career he headed development programs leading to the approval...
MOUNTAIN VIEW, Calif., July 23 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. today announced the appointment of Donald J. Kellerman, Pharm.D. to the position of Senior Vice President, Clinical Development and Medical Affairs. Dr. Kellerman brings to MAP Pharmaceuticals more than 25 years of clinical experience, serving as...
LONDON -- Novartis AG's Sandoz unit is working with British inhaled drug specialist Vectura Group on generic versions of today's blockbuster asthma drugs, the head of the Swiss company's generics business has disclosed. Sandoz chief executive officer Andreas Rummelt says such dry powder combination products as GlaxoSmithKline PLC's...
FOOD AND BEVERAGE CLOSE-UP-26 June 2008-Harris Interactive: Heinz Ketchup Ranks No. 1 in Overall Brand EquityC2008 - CloseUpMedia - newsdesk@closeupmedia.com Harris Interactive has released the 2008 results from EquiTrend, a 28-year brand equity study that measures more than 1,000 brands across 39 categories. ...
THE WEEK IN REVIEW Earnings at the drugs giant GlaxoSmithKline will almost certainly be down this year. With the stock falling from 1385p in January, investors are wising up to the fact that pharmaceutical stocks are not a safe haven, given patent challenges...
THE INVESTMENT COLUMN Our view: Sell Share price: 1053p (-11p) By drug giant GlaxoSmithKline's own admission, this financial year will not be the shot in the arm that investors might have been hoping for as earnings will...
The Food and Drug Administration approved expanded use of the asthma drug Advair to reduce exacerbations of chronic obstructive pulmonary disease. Inhaled Advair, taken by way of the manufacturer GlaxoSmithKline's Diskus device, combines 250 mcg of fluticasone propionate a corticosteroid with 50 mcg of salmeterol xinafoate (a long-acting...
Upstate New Yorkers are spending a lot of money on prescription drugs, according to a new report from Excellus BlueCross BlueShield, the region's largest health in-surer. Of the more than 3,000 drugs prescribed in Upstate in 2007, 10 brand-name drugs accounted for about 20 percent of the total...
The Food and Drug Administration has approved GlaxoSmithKline's asthma drug Advair to be used more widely to treat patients with chronic obstructive pulmonary disease, according to published reports. The drug had been approved to prevent wheezing and control other symptoms in COPD patients. GSK's approval...
Positive Data Used by the FDA to Expand Use of Advair Last Month TORONTO and RESEARCH TRIANGLE PARK, N.C., May 18 /PRNewswire-FirstCall/ -- The use of Advair DiskusR 250/50 fluticasone propionate and salmeterol inhalation powder demonstrated a 30% reduction in exacerbations in patients with chronic obstructive pulmonary...
Study Suggests that Adding Singulair to Advair Offers no Additional Improvement in Overall Asthma Control RESEARCH TRIANGLE PARK, N.C. and TORONTO, May 18 /PRNewswire-FirstCall/ -- Patients with both asthma and allergic rhinitis, or seasonal allergies, experience significantly better lung function when treated with Advair DiskusR (fluticasone propionate...
Study is the Largest Prospective Trial to Examine Asthma Outcomes Based on Genetic Profile RESEARCH TRIANGLE PARK, N.C. and PHILADELPHIA, March 16 /PRNewswire/ -- Data presented today by GlaxoSmithKline showed that genetic differences at the site of the beta-2 adrenergic receptor gene in asthma patients did not...
Two Observational Studies Examine Impact of Advair in Asthma Patients RESEARCH TRIANGLE PARK, N.C. and PHILADELPHIA, March 15 /PRNewswire/ -- Advair DiskusR fluticasone propionate and salmeterol inhalation powder was associated with fewer asthma-related hospitalizations and emergency department ED visits in pediatric patients when compared to the use...
FDA March 5 requested additional information from manufacturers of certain asthma drugs as part of an ongoing safety review of the drugs in children, CNNMoney reported this week. The agency also said it will schedule another advisory panel later this year or early next year to evaluate any...
MERCK PUT Fosamax alendronate sodium and its $3 billion in total 2007 sales in its rear-view mirror last month, following the lapse of patent protection on the osteoporosis drug. Merck forecast that 2008 sales will decline by at least half that, followed by more attrition later. Fosamax is part...
Although Physicians Report Satisfaction with GlaxoSmithKline's Advair and Boehringer Ingelheim/Pfizer's Spiriva, Significant Need Remains for a Novel Anti-Inflammatory Drug, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical...
The FDA is questioning the safety of some asthma medications for children. In particular, it is examining the appropriateness of GlaxoSmithKline PLC's Advair and Serevent for that age group...
Articles 2007-12-17
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
With AT&T Tech Support 360, you'll have certified, U.S. based technicians on call 24/7 to help keep your computers, connections, software and peripherals up to speed for just 82¢ a day.
